NMC
TOI icon

Nine Masts Capital’s The Oncology Institute TOI Stock Holding History

Nine Masts Capital’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43K Buy
+14,018
New +$43K 0.01% 165

Other funds holding TOI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nine Masts Capital's TOI Position: Q1 2026 in Review

Nine Masts Capital opened a new position in The Oncology Institute (TOI) in Q1 2026: 14,018 shares worth $43K. The stake represents 0.01% of the portfolio and ranks #165 among its holdings.

115 funds tracked by Wall St. Rank hold TOI as of Q1 2026.

  • Nine Masts Capital held 14,018 shares of The Oncology Institute worth $43K as of Q1 2026.
  • The Oncology Institute was a new Nine Masts Capital position in Q1 2026.
  • The Oncology Institute made up 0.01% of Nine Masts Capital's portfolio in Q1 2026, its #165 holding.
  • 115 funds tracked by Wall St. Rank held The Oncology Institute as of Q1 2026.

Based on Nine Masts Capital's 13F filing for Q1 2026, filed 13 May 2026.